Cargando…

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy

Despite the progress made in risk stratification, sudden cardiac death and heart failure remain dreaded complications for hypertrophic cardiomyopathy (HCM) patients. Myocardial ischaemia is widely acknowledged as a contributor to cardiovascular events, but the assessment of ischaemia is not yet incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coleman, James A., Ashkir, Zakariye, Raman, Betty, Bueno-Orovio, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589194/ https://www.ncbi.nlm.nih.gov/pubmed/37358707 http://dx.doi.org/10.1007/s10554-023-02894-y

Ejemplares similares

Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
por: Palandri, Chiara, et al.
Publicado: (2022)

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
por: Farrant, John, et al.
Publicado: (2023)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
por: Lyon, Aurore, et al.
Publicado: (2018)

Four-dimensional flow cardiac magnetic resonance assessment of left ventricular diastolic function
por: Ashkir, Zakariye, et al.
Publicado: (2022)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)

Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischaemia and its modulation by sodium current availability
por: Martinez-Navarro, Hector, et al.
Publicado: (2021)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Margara, Francesca, et al.
Publicado: (2022)

Mechanisms of Painless Myocardial Ischaemia
por: Glazier, James J., et al.
Publicado: (1991)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, Betty, et al.
Publicado: (2019)

Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias
por: Ariga, Rina, et al.
Publicado: (2019)

ABNORMAL SKELETAL METABOLISM BUT NOT CARDIAC DYSFUNCTION AS A CAUSE FOR FATIGUE POST COVID-19
por: Cassar, Mark Philip, et al.
Publicado: (2023)

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis
por: Ashkir, Z, et al.
Publicado: (2023)

Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
por: Lyon, A., et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
por: Burban, Anna, et al.
Publicado: (2023)

Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function
por: Coppini, Raffaele, et al.
Publicado: (2022)

Hypertrophic preconditioning cardioprotection after myocardial ischaemia/reperfusion injury involves ALDH2-dependent metabolism modulation
por: Ma, Lei-Lei, et al.
Publicado: (2021)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
por: Bernardini, Andrea, et al.
Publicado: (2023)

Stress cardiomyopathy in a patient with hypertrophic cardiomyopathy and myocardial bridging
por: Benavides, Miguel, et al.
Publicado: (2017)

The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2020)

Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart
por: Ma, Lei‐Lei, et al.
Publicado: (2018)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Toward a broader view of mechanisms of drug cardiotoxicity
por: Mamoshina, Polina, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022)

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers
por: Hughes, Rebecca K., et al.
Publicado: (2021)

Prevalence and prognostic implications of hypertensive response to exercise in patients with hypertrophic cardiomyopathy()
por: Lu, Dai-Yin, et al.
Publicado: (2023)

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
por: Hermida, Uxio, et al.
Publicado: (2022)

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction
por: Chou, Chun, et al.
Publicado: (2021)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study
por: Coppini, Raffaele, et al.
Publicado: (2019)

The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy
por: Kittleson, Mark D, et al.
Publicado: (2021)

Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
por: Roldan, Paola, et al.
Publicado: (2022)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

The genetics of hypertrophic cardiomyopathy
por: Akhtar, Mohammed, et al.
Publicado: (2018)

Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy
por: Malahfji, Maan, et al.
Publicado: (2020)

An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
por: van de Sande, Danny A. J. P., et al.
Publicado: (2014)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6sujjmjrnaivn5ec5tt80cs2cc